Phenol-soluble modulins - critical determinants of staphylococcal virulence

FEMS Microbiology Reviews

Volumn 38, Issue 4, 2014, Pages 698-719

  Cheung, Gordon Y C ^a   Joo, Hwang Soo ^a   Chatterjee, Som S ^a   Otto, Michael ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Biofilm; Phenol soluble modulin; Staphylococcus aureus; Staphylococcus epidermidis; Toxin; Virulence

Indexed keywords

BACTERIAL PROTEIN; PHENOL SOLUBLE MODULIN; UNCLASSIFIED DRUG;

ALPHA HELIX; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BIOFILM; COMMENSAL; CYTOLYSIS; ERYTHROCYTE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE; NONHUMAN; PATHOGENESIS; PROTEIN FAMILY; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

BIOFILM; PHENOL-SOLUBLE MODULIN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TOXIN; VIRULENCE;

BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; HOST-PATHOGEN INTERACTIONS; IMMUNOLOGIC FACTORS; PHENOL; PROTEIN TRANSPORT; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 84904054033     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1111/1574-6976.12057     Document Type: Review

References (145)

1. Abdelnour A, Arvidson S, Bremell T, Ryden C & Tarkowski A (1993) The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun 61: 3879-3885.
2. Adhikari RP, Ajao AO, Aman MJ, Karauzum H, Sarwar J, Lydecker AD, Johnson JK, Nguyen C, Chen WH & Roghmann MC (2012) Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections. J Infect Dis 206: 915-923.
3. Adkins I, Holubova J, Kosova M & Sadilkova L (2012) Bacteria and their toxins tamed for immunotherapy. Curr Pharm Biotechol 13: 1446-1473.
4. Alonzo F 3rd, Benson MA, Chen J, Novick RP, Shopsin B & Torres VJ (2012) Staphylococcus aureus leukocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Mol Microbiol 83: 423-435.
5. Alonzo F 3rd, Kozhaya L, Rawlings SA, Reyes-Robles T, DuMont AL, Myszka DG, Landau NR, Unutmaz D & Torres VJ (2013) CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature 493: 51-55.
6. Amulic B, Cazalet C, Hayes GL, Metzler KD & Zychlinsky A (2012) Neutrophil function: from mechanisms to disease. Annu Rev Immunol 30: 459-489.
7. Angelini TE, Roper M, Kolter R, Weitz DA & Brenner MP (2009) Bacillus subtilis spreads by surfing on waves of surfactant. P Natl Acad Sci USA 106: 18109-18113.
8. Arnold SR, Elias D, Buckingham SC, Thomas ED, Novais E, Arkader A & Howard C (2006) Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus. J Pediatr Orthop 26: 703-708.
9. Bartlett AH, Foster TJ, Hayashida A & Park PW (2008) Alpha-toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia. J Infect Dis 198: 1529-1535.
10. Beaudet R, Bisaillon JG, Saheb SA & Sylvestre M (1982) Production, purification, and preliminary characterization of a gonococcal growth inhibitor produced by a coagulase-negative staphylococcus isolated from the urogenital flora. Antimicrob Agents Chemother 22: 277-283.
11. Bhakdi S & Tranum-Jensen J (1991) Alpha-toxin of Staphylococcus aureus. Microbiol Rev 55: 733-751.
12. Bocchini CE, Hulten KG, Mason EO Jr, Gonzalez BE, Hammerman WA & Kaplan SL (2006) Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics 117: 433-440.
13. Boles BR, Thoendel M & Singh PK (2005) Rhamnolipids mediate detachment of Pseudomonas aeruginosa from biofilms. Mol Microbiol 57: 1210-1223.
14. Branda SS, Gonzalez-Pastor JE, Ben-Yehuda S, Losick R & Kolter R (2001) Fruiting body formation by Bacillus subtilis. P Natl Acad Sci USA 98: 11621-11626.
15. Brown EL, Dumitrescu O, Thomas D et al. (2009) The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect 15: 156-164.
16. Carnes EC, Lopez DM, Donegan NP, Cheung A, Gresham H, Timmins GS & Brinker CJ (2010) Confinement-induced quorum sensing of individual Staphylococcus aureus bacteria. Nat Chem Biol 6: 41-45.
17. Cassat JE, Hammer ND, Campbell JP, Benson MA, Perrien DS, Mrak LN, Smeltzer MS, Torres VJ & Skaar EP (2013) A secreted bacterial protease tailors the Staphylococcus aureus virulence repertoire to modulate bone remodeling during osteomyelitis. Cell Host Microbe 13: 759-772.
18. Chaffin DO, Taylor D, Skerrett SJ & Rubens CE (2012) Changes in the Staphylococcus aureus transcriptome during early adaptation to the lung. PLoS One 7: e41329.
19. Chatterjee SS & Otto M (2013) How can Staphylococcus aureus phenol-soluble modulins be targeted to inhibit infection? Future Microbiol 8: 693-696.
20. Chatterjee SS, Chen L, Joo HS, Cheung GY, Kreiswirth BN & Otto M (2011) Distribution and regulation of the mobile genetic element-encoded phenol-soluble modulin PSM-mec in methicillin-resistant Staphylococcus aureus. PLoS One 6: e28781.
21. Chatterjee SS, Joo HS, Duong AC, Dieringer TD, Tan VY, Song Y, Fischer ER, Cheung GY, Li M & Otto M (2013) Essential Staphylococcus aureus toxin export system. Nat Med 19: 364-367.
22. Cheung GY & Otto M (2011) Direct and synergistic hemolysis caused by Staphylococcus phenol-soluble modulins: implications for diagnosis and pathogenesis. Microbes Infect 14: 380-386.
23. Cheung GY & Otto M (2012) The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections. Expert Opin Ther Targets 16: 601-612.
24. Cheung AL, Eberhardt KJ, Chung E, Yeaman MR, Sullam PM, Ramos M & Bayer AS (1994) Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. J Clin Invest 94: 1815-1822.
25. Cheung GY, Rigby K, Wang R, Queck SY, Braughton KR, Whitney AR, Teintze M, DeLeo FR & Otto M (2010) Staphylococcus epidermidis strategies to avoid killing by human neutrophils. PLoS Pathog 6: e1001133.
26. Cheung GY, Wang R, Khan BA, Sturdevant DE & Otto M (2011) Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Infect Immun 79: 1927-1935.
27. Cheung GY, Kretschmer D, Queck SY et al. (2014) Insight into structure-function relationship in phenol-soluble modulins using an alanine screen of the phenol-soluble modulin (PSM) alpha3 peptide. FASEB J 28: 153-161.
28. Cogen AL, Yamasaki K, Muto J, Sanchez KM, Crotty Alexander L, Tanios J, Lai Y, Kim JE, Nizet V & Gallo RL (2010a) Staphylococcus epidermidis antimicrobial delta-toxin (phenol-soluble modulin-gamma) cooperates with host antimicrobial peptides to kill group A Streptococcus. PLoS One 5: e8557.
29. Cogen AL, Yamasaki K, Sanchez KM et al. (2010b) Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol 130: 192-200.
30. Costerton JW, Stewart PS & Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322.
31. de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, Poppelier MJ, Van Kessel KP & van Strijp JA (2004) Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 199: 687-695.
32. DeLeo FR & Otto M (2008) An antidote for Staphylococcus aureus pneumonia? J Exp Med 205: 271-274.
33. DeLeo FR, Otto M, Kreiswirth BN & Chambers HF (2010) Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375: 1557-1568.
34. Devaux PF & Morris R (2004) Transmembrane asymmetry and lateral domains in biological membranes. Traffic 5: 241-246.
35. Dhople VM & Nagaraj R (1995) Generation of analogs having potent antimicrobial and hemolytic activities with minimal changes from an inactive 16-residue peptide corresponding to the helical region of Staphylococcus aureus delta-toxin. Protein Eng 8: 315-318.
36. Dhople VM & Nagaraj R (2005) Conformation and activity of delta-lysin and its analogs. Peptides 26: 217-225.
37. Diep BA, Gill SR, Chang RF et al. (2006) Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 367: 731-739.
38. Diep BA, Chan L, Tattevin P et al. (2010) Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. P Natl Acad Sci USA 107: 5587-5592.
39. Donvito B, Etienne J, Denoroy L, Greenland T, Benito Y & Vandenesch F (1997) Synergistic hemolytic activity of Staphylococcus lugdunensis is mediated by three peptides encoded by a non-agr genetic locus. Infect Immun 65: 95-100.
40. Dorschner RA, Lopez-Garcia B, Peschel A, Kraus D, Morikawa K, Nizet V & Gallo RL (2006) The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. Faseb J 20: 35-42.
41. Dumont AL, Nygaard TK, Watkins RL, Smith A, Kozhaya L, Kreiswirth BN, Shopsin B, Unutmaz D, Voyich JM & Torres VJ (2011) Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol Microbiol 79: 814-825.
42. DuMont AL, Yoong P, Day CJ, Alonzo F 3rd, McDonald WH, Jennings MP & Torres VJ (2013) Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1. P Natl Acad Sci USA 110: 10794-10799.
43. Duong AC, Cheung GY & Otto M (2012) Interaction of phenol-soluble modulins with phosphatidylcholine vesicles. Pathogens 1: 3-11.
44. Ezepchuk YV, Leung DY, Middleton MH, Bina P, Reiser R & Norris DA (1996) Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes. J Invest Dermatol 107: 603-609.
45. Forsman H, Christenson K, Bylund J & Dahlgren C (2012) Receptor-dependent and -independent immunomodulatory effects of phenol-soluble modulin peptides from Staphylococcus aureus on human neutrophils are abrogated through peptide inactivation by reactive oxygen species. Infect Immun 80: 1987-1995.
46. Fu H, Karlsson J, Bylund J, Movitz C, Karlsson A & Dahlgren C (2006) Ligand recognition and activation of formyl peptide receptors in neutrophils. J Leukoc Biol 79: 247-256.
47. Galli SJ & Tsai M (2012) IgE and mast cells in allergic disease. Nat Med 18: 693-704.
48. Galli SJ, Borregaard N & Wynn TA (2011) Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 12: 1035-1044.
49. Geiger T, Francois P, Liebeke M, Fraunholz M, Goerke C, Krismer B, Schrenzel J, Lalk M & Wolz C (2012) The stringent response of Staphylococcus aureus and its impact on survival after phagocytosis through the induction of intracellular PSMs expression. PLoS Pathog 8: e1003016.
50. Giese B, Glowinski F, Paprotka K, Dittmann S, Steiner T, Sinha B & Fraunholz MJ (2011) Expression of delta-toxin by Staphylococcus aureus mediates escape from phago-endosomes of human epithelial and endothelial cells in the presence of beta-toxin. Cell Microbiol 13: 316-329.
51. Gill SR, Fouts DE, Archer GL et al. (2005) Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol 187: 2426-2438.
52. Gillaspy AF, Hickmon SG, Skinner RA, Thomas JR, Nelson CL & Smeltzer MS (1995) Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis. Infect Immun 63: 3373-3380.
53. Gonzalez DJ, Okumura CY, Hollands A et al. (2012) Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry. J Biol Chem 287: 13889-13898.
54. Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL & Lindberg FP (2000) Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol 164: 3713-3722.
55. Grosz M, Kolter J, Paprotka K et al. (2013) Cytoplasmic replication of Staphylococcus aureus upon phagosomal escape triggered by phenol-soluble modulin α. Cell Microbiol DOI: 10.1111/cmi.12233, [Epub ahead of print].
56. Hocke AC, Temmesfeld-Wollbrueck B, Schmeck B, Berger K, Frisch EM, Witzenrath M, Brell B, Suttorp N & Hippenstiel S (2006) Perturbation of endothelial junction proteins by Staphylococcus aureus alpha-toxin: inhibition of endothelial gap formation by adrenomedullin. Histochem Cell Biol 126: 305-316.
57. Hongo I, Baba T, Oishi K, Morimoto Y, Ito T & Hiramatsu K (2009) Phenol-soluble modulin alpha 3 enhances the human neutrophil lysis mediated by Panton-Valentine leukocidin. J Infect Dis 200: 715-723.
58. Inoshima I, Inoshima N, Wilke GA, Powers ME, Frank KM, Wang Y & Bubeck Wardenburg J (2011) A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat Med 17: 1310-1314.
59. Joo HS & Otto M (2014) The isolation and analysis of phenol-soluble modulins of Staphylococcus epidermidis. Methods Mol Biol 1106: 93-100.
60. Joo HS, Cheung GY & Otto M (2011) Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives. J Biol Chem 286: 8933-8940.
61. Kaito C, Saito Y, Nagano G et al. (2011) Transcription and translation products of the cytolysin gene psm-mec on the mobile genetic element SCCmec regulate Staphylococcus aureus virulence. PLoS Pathog 7: e1001267.
62. Kaito C, Saito Y, Ikuo M et al. (2013) Mobile genetic element SCCmec-encoded psm-mec RNA suppresses translation of agrA and attenuates MRSA virulence. PLoS Pathog 9: e1003269.
63. Kennedy AD, Bubeck Wardenburg J, Gardner DJ, Long D, Whitney AR, Braughton KR, Schneewind O & DeLeo FR (2010) Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis 202: 1050-1058.
64. Klevens RM, Morrison MA, Nadle J et al. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298: 1763-1771.
65. Kobayashi SD, Braughton KR, Palazzolo-Ballance AM et al. (2010) Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J Innate Immun 2: 560-575.
66. Kobayashi SD, Malachowa N, Whitney AR, Braughton KR, Gardner DJ, Long D, Bubeck Wardenburg J, Schneewind O, Otto M & DeLeo FR (2011) Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 204: 937-941.
67. Kogan G, Sadovskaya I, Chaignon P, Chokr A & Jabbouri S (2006) Biofilms of clinical strains of Staphylococcus that do not contain polysaccharide intercellular adhesin. FEMS Microbiol Lett 255: 11-16.
68. Kreger AS & Bernheimer AW (1971) Disruption of bacterial protoplasts and spheroplasts by staphylococcal delta hemolysin. Infect Immun 3: 603-605.
69. Kretschmer D, Gleske AK, Rautenberg M et al. (2010) Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe 7: 463-473.
70. Kretschmer D, Nikola N, Durr M, Otto M & Peschel A (2011) The virulence regulator Agr controls the staphylococcal capacity to activate human neutrophils via the formyl peptide receptor 2. J Innate Immun 4: 201-212.
71. Kubica M, Guzik K, Koziel J et al. (2008) A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS One 3: e1409.
72. Li M, Diep BA, Villaruz AE, Braughton KR, Jiang X, DeLeo FR, Chambers HF, Lu Y & Otto M (2009) Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. P Natl Acad Sci USA 106: 5883-5888.
73. Li M, Cheung GY, Hu J, Wang D, Joo HS, DeLeo FR & Otto M (2010) Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains. J Infect Dis 202: 1866-1876.
74. Liang X & Ji Y (2006) Alpha-toxin interferes with integrin-mediated adhesion and internalization of Staphylococcus aureus by epithelial cells. Cell Microbiol 8: 1656-1668.
75. Liles WC, Thomsen AR, O'Mahony DS & Klebanoff SJ (2001) Stimulation of human neutrophils and monocytes by staphylococcal phenol-soluble modulin. J Leukoc Biol 70: 96-102.
76. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532.
77. Lowy FD (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111: 1265-1273.
78. Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, Hammerman W, Mason EO Jr & Kaplan SL (2004) Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 23: 701-706.
79. Mehlin C, Headley CM & Klebanoff SJ (1999) An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization. J Exp Med 189: 907-918.
80. Migeotte I, Communi D & Parmentier M (2006) Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev 17: 501-519.
81. Monecke S, Engelmann I, Archambault M et al. (2012) Distribution of SCCmec-associated phenol-soluble modulin in staphylococci. Mol Cell Probes 26: 99-103.
82. Nakamura Y, Oscherwitz J, Cease KB et al. (2013) Staphylococcus δ-toxin promotes allergic skin disease by inducing mast cell degranulation. Nature 503: 397-401.
83. Nolte FS & Kapral FA (1981) Immunogenicity of Staphylococcus aureus delta-toxin. Infect Immun 31: 1251-1260.
84. Novick RP (2003) Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48: 1429-1449.
85. Novick RP, Schlievert P & Ruzin A (2001) Pathogenicity and resistance islands of staphylococci. Microbes Infect 3: 585-594.
86. Oogai Y, Matsuo M, Hashimoto M, Kato F, Sugai M & Komatsuzawa H (2011) Expression of virulence factors by Staphylococcus aureus grown in serum. Appl Environ Microbiol 77: 8097-8105.
87. Otto M (2008) Staphylococcal biofilms. Curr Top Microbiol Immunol 322: 207-228.
88. Otto M (2009) Staphylococcus epidermidis-the 'accidental' pathogen. Nat Rev Microbiol 7: 555-567.
89. Otto M (2010) Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu Rev Microbiol 64: 143-162.
90. Otto M (2011) A MRSA-terious enemy among us: end of the PVL controversy? Nat Med 17: 169-170.
91. Otto M (2013a) Coagulase-negative staphylococci as reservoirs of genes facilitating MRSA infection: Staphylococcal commensal species such as Staphylococcus epidermidis are being recognized as important sources of genes promoting MRSA colonization and virulence. BioEssays 35: 4-11.
92. Otto M (2013b) Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity. Annu Rev Med 64: 175-188.
93. Otto M, O'Mahoney DS, Guina T & Klebanoff SJ (2004) Activity of Staphylococcus epidermidis phenol-soluble modulin peptides expressed in Staphylococcus carnosus. J Infect Dis 190: 748-755.
94. Pang YY, Schwartz J, Thoendel M, Ackermann LW, Horswill AR & Nauseef WM (2010) agr-Dependent interactions of Staphylococcus aureus USA300 with human polymorphonuclear neutrophils. J Innate Immun 2: 546-559.
95. Periasamy S, Joo HS, Duong AC, Bach TH, Tan VY, Chatterjee SS, Cheung GY & Otto M (2012) How Staphylococcus aureus biofilms develop their characteristic structure. P Natl Acad Sci USA 109: 1281-1286.
96. Pokorny A, Birkbeck TH & Almeida PF (2002) Mechanism and kinetics of delta-lysin interaction with phospholipid vesicles. Biochemistry 41: 11044-11056.
97. Prat C, Bestebroer J, Haas CJ, van Strijp JA & van Kessel KP (2006) A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1. J Immunol 177: 8017-8026.
98. Proctor RA (2012) Challenges for a universal Staphylococcus aureus vaccine. Clin Infect Dis 54: 1179-1186.
99. Queck SY, Jameson-Lee M, Villaruz AE, Bach TH, Khan BA, Sturdevant DE, Ricklefs SM, Li M & Otto M (2008) RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol Cell 32: 150-158.
100. Queck SY, Khan BA, Wang R, Bach TH, Kretschmer D, Chen L, Kreiswirth BN, Peschel A, DeLeo FR & Otto M (2009) Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA. PLoS Pathog 5: e1000533.
101. Rasigade JP, Trouillet-Assant S, Ferry T et al. (2013) PSMs of hypervirulent Staphylococcus aureus act as intracellular toxins that kill infected osteoblasts. PLoS One 8: e63176.
102. Rautenberg M, Joo HS, Otto M & Peschel A (2011) Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence. FASEB J 25: 1254-1263.
103. Rigby KM & DeLeo FR (2012) Neutrophils in innate host defense against Staphylococcus aureus infections. Semin Immunopathol 34: 237-259.
104. Rimland D & Roberson B (1986) Gastrointestinal carriage of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 24: 137-138.
105. Rogers DE (1956) Studies on bacteriemia. I. Mechanisms relating to the persistence of bacteriemia in rabbits following the intravenous injection of staphylococci. J Exp Med 103: 713-742.
106. Rogers KL, Fey PD & Rupp ME (2009) Coagulase-negative staphylococcal infections. Infect Dis Clin North Am 23: 73-98.
107. Rohde H, Burandt EC, Siemssen N et al. (2007) Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials 28: 1711-1720.
108. Rudikoff D & Lebwohl M (1998) Atopic dermatitis. Lancet 351: 1715-1721.
109. Scheifele DW, Bjornson GL, Dyer RA & Dimmick JE (1987) Delta-like toxin produced by coagulase-negative staphylococci is associated with neonatal necrotizing enterocolitis. Infect Immun 55: 2268-2273.
110. Schreiner J, Kretschmer D, Klenk J, Otto M, Buhring HJ, Stevanovic S, Wang JM, Beer-Hammer S, Peschel A & Autenrieth SE (2013) Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells. J Immunol 190: 3417-3426.
111. Schwartz K, Syed AK, Stephenson RE, Rickard AH & Boles BR (2012) Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms. PLoS Pathog 8: e1002744.
112. Somerville GA, Cockayne A, Durr M, Peschel A, Otto M & Musser JM (2003) Synthesis and deformylation of Staphylococcus aureus delta-toxin are linked to tricarboxylic acid cycle activity. J Bacteriol 185: 6686-6694.
113. Spaan AN, Henry T, van Rooijen WJ et al. (2013) The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors. Cell Host Microbe 13: 584-594.
114. Spaulding AR, Lin YC, Merriman JA, Brosnahan AJ, Peterson ML & Schlievert PM (2012) Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses. Vaccine 30: 5099-5109.
115. Spellberg B & Daum R (2011) Development of a vaccine against Staphylococcus aureus. Semin Immunopathol 34: 335-348.
116. Spentzas T, Kudumula R, Acuna C, Talati AJ, Ingram KC, Savorgnan F, Meals EA & English BK (2011) Role of bacterial components in macrophage activation by the LAC and MW2 strains of community-associated, methicillin-resistant Staphylococcus aureus. Cell Immunol 269: 46-53.
117. Sugimoto S, Iwamoto T, Takada K, Okuda K, Tajima A, Iwase T & Mizunoe Y (2013) Staphylococcus epidermidis Esp degrades specific proteins associated with Staphylococcus aureus biofilm formation and host-pathogen interaction. J Bacteriol 195: 1645-1655.
118. Surewaard BG, Nijland R, Spaan AN, Kruijtzer JA, de Haas CJ & van Strijp JA (2012) Inactivation of staphylococcal phenol soluble modulins by serum lipoprotein particles. PLoS Pathog 8: e1002606.
119. Surewaard BG, de Haas CJ, Vervoort F, Rigby KM, DeLeo FR, Otto M, van Strijp JA & Nijland R (2013) Staphylococcal alpha-phenol soluble modulins contribute to neutrophil lysis after phagocytosis. Cell Microbiol 15: 1427-1437.
120. Szmigielski S, Prevost G, Monteil H, Colin DA & Jeljaszewicz J (1999) Leukocidal toxins of staphylococci. Zentralbl Bakteriol 289: 185-201.
121. Tappin MJ, Pastore A, Norton RS, Freer JH & Campbell ID (1988) High-resolution 1H NMR study of the solution structure of delta-hemolysin. Biochemistry 27: 1643-1647.
122. Thelestam M, Mollby R & Wadstrom T (1973) Effects of staphylococcal alpha-, beta-, delta-, and gamma-hemolysins on human diploid fibroblasts and HeLa cells: evaluation of a new quantitative as say for measuring cell damage. Infect Immun 8: 938-946.
123. Thwaites GE & Gant V (2011) Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus? Nat Rev Microbiol 9: 215-222.
124. Traber KE, Lee E, Benson S, Corrigan R, Cantera M, Shopsin B & Novick RP (2008) Agr function in clinical Staphylococcus aureus isolates. Microbiology 154: 2265-2274.
125. Tsompanidou E, Denham EL, Becher D, de Jong A, Buist G, van Oosten M, Manson WL, Back JW, van Dijl JM & Dreisbach A (2013) Distinct roles of phenol-soluble modulins in spreading of Staphylococcus aureus on wet surfaces. Appl Environ Microbiol 79: 886-895.
126. Tuchscherr L, Heitmann V, Hussain M, Viemann D, Roth J, von Eiff C, Peters G, Becker K & Loffler B (2010) Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis 202: 1031-1040.
127. Tuchscherr L, Medina E, Hussain M et al. (2011) Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med 3: 129-141.
128. Valeva A, Walev I, Pinkernell M, Walker B, Bayley H, Palmer M & Bhakdi S (1997) Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. P Natl Acad Sci USA 94: 11607-11611.
129. Vander Have KL, Karmazyn B, Verma M, Caird MS, Hensinger RN, Farley FA & Lubicky JP (2009) Community-associated methicillin-resistant Staphylococcus aureus in acute musculoskeletal infection in children: a game changer. J Pediatr Orthop 29: 927-931.
130. Ventura CL, Malachowa N, Hammer CH, Nardone GA, Robinson MA, Kobayashi SD & DeLeo FR (2010) Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics. PLoS One 5: e11634.
131. Verdon J, Berjeaud JM, Lacombe C & Hechard Y (2008) Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri. Peptides 29: 978-984.
132. Verdon J, Girardin N, Lacombe C, Berjeaud JM & Hechard Y (2009) delta-hemolysin, an update on a membrane-interacting peptide. Peptides 30: 817-823.
133. von Eiff C, Becker K, Machka K, Stammer H & Peters G (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 344: 11-16.
134. Voyich JM, Braughton KR, Sturdevant DE et al. (2005) Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 175: 3907-3919.
135. Vuong C, Kocianova S, Yao Y, Carmody AB & Otto M (2004a) Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo. J Infect Dis 190: 1498-1505.
136. Vuong C, Durr M, Carmody AB, Peschel A, Klebanoff SJ & Otto M (2004b) Regulated expression of pathogen-associated molecular pattern molecules in Staphylococcus epidermidis: quorum-sensing determines pro-inflammatory capacity and production of phenol-soluble modulins. Cell Microbiol 6: 753-759.
137. Walev I, Martin E, Jonas D, Mohamadzadeh M, Muller-Klieser W, Kunz L & Bhakdi S (1993) Staphylococcal alpha-toxin kills human keratinocytes by permeabilizing the plasma membrane for monovalent ions. Infect Immun 61: 4972-4979.
138. Wang R, Braughton KR, Kretschmer D et al. (2007) Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13: 1510-1514.
139. Wang R, Khan BA, Cheung GY, Bach TH, Jameson-Lee M, Kong KF, Queck SY & Otto M (2011) Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. J Clin Invest 121: 238-248.
140. Watson DC, Yaguchi M, Bisaillon JG, Beaudet R & Morosoli R (1988) The amino acid sequence of a gonococcal growth inhibitor from Staphylococcus haemolyticus. Biochem J 252: 87-93.
141. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA & Nouwen JL (2005) The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5: 751-762.
142. Wilke GA & Bubeck Wardenburg J (2010) Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury. P Natl Acad Sci USA 107: 13473-13478.
143. Williams H & Flohr C (2006) How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol 118: 209-213.
144. Yao Y, Sturdevant DE & Otto M (2005) Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms. J Infect Dis 191: 289-298.
145. Zielinska AK, Beenken KE, Joo HS, Mrak LN, Griffin LM, Luong TT, Lee CY, Otto M, Shaw LN & Smeltzer MS (2011) Defining the strain-dependent impact of the Staphylococcal accessory regulator (sarA) on the alpha-toxin phenotype of Staphylococcus aureus. J Bacteriol 193: 2948-2958.